JP Morgan Chase
ONEM

JP Morgan Chase’s 1Life Healthcare ONEM Stock Holding History

JP Morgan Chase’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,100
Closed -$36K – 7257
2022
Q3 		$36K Hold
2,100
– – ﹤0.01% 5644
2022
Q2 		$16K Sell
2,100
-647,900
-100% -$5.57M ﹤0.01% 5944
2022
Q1 		$7.2M Buy
+650,000
New +$7.28M ﹤0.01% 2683

JP Morgan Chase's ONEM Position: Q1 2023 in Review

JP Morgan Chase sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 843,209 shares — an estimated $14.1M sold.

JP Morgan Chase first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $36.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • JP Morgan Chase reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 843,209 1Life Healthcare shares in Q1 2023, an estimated $14.1M.
  • JP Morgan Chase first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • JP Morgan Chase's 1Life Healthcare position peaked at $36.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.